deltatrials
Completed PHASE2 NCT00214136

Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes

A Phase II Prostate Cancer Trial Treating Pelvic Lymph Nodes to High Dose Using Intensity Modulated Radiation Therapy

Sponsor: National Cancer Institute (NCI)

Conditions Prostate Cancer
Interventions radiotherapy
Updated 8 times since 2017 Last updated: Aug 2, 2021 Started: Mar 31, 2005 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

Listed as NCT00214136, this PHASE2 trial focuses on Prostate Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 8 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE2

  5. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2020 [monthly]

    Completed PHASE2

  2. Feb 2018 — Jun 2018 [monthly]

    Completed PHASE2

  3. Jan 2017 — Feb 2018 [monthly]

    Completed PHASE2

    First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Wisconsin, Madison
Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Madison, United States